10-Q: RGA Q3 2025 Earnings: Equitable Deal Boosts Income

Reinsurance Group of America reports increased pre-tax income for Q3 2025, driven by the Equitable transaction and favorable assumption updates, despite a decline in nine-month adjusted operating income.

Summary

• Net income available to RGA, Inc. shareholders increased to $253 million for the three months ended September 30, 2025, compared to $156 million for the same period in 2024.
• Diluted earnings per share rose to $3.81 for Q3 2025, up from $2.33 in Q3 2024.
• For the nine months ended September 30, 2025, net income available to RGA, Inc. shareholders was $719 million, an increase from $569 million in the prior year period.
• Pre-tax income increased by $106 million for Q3 2025 and $275 million for the nine months ended September 30, 2025.
• The transaction with Equitable Holdings, Inc. on July 31, 2025, contributed $37 million to the U.S. Financial Solutions segment's adjusted operating income and resulted in a $21 million gain for the U.S. Traditional segment due to risk recapture.
• Net premiums decreased by $111 million for Q3 2025 and $1,237 million for the nine months ended September 30, 2025, primarily due to single premium pension risk transfer (PRT) transactions in 2024.
• Net investment income increased by $287 million for Q3 2025 and $884 million for the nine months ended September 30, 2025, driven by an increase in invested assets and higher new money rates.
• The annual assumption review in Q3 2025 resulted in a $149 million loss, primarily due to updated mortality assumptions in the U.K. (EMEA Traditional segment).
• Adjusted operating income before income taxes increased by $71 million for Q3 2025 but decreased by $30 million for the nine months ended September 30, 2025.
• Total cash and invested assets grew to $132.2 billion as of September 30, 2025, from $101.4 billion at December 31, 2024.
• Life reinsurance in force increased to $4,320.8 billion as of September 30, 2025, from $3,966.5 billion as of September 30, 2024.
• The company repurchased 406,337 shares of common stock during the nine months ended September 30, 2025, with $425 million remaining under the share repurchase authorization.

Sentiment

Score: 7

Explanation: The company demonstrated strong net income and EPS growth for Q3 2025, significantly boosted by the strategic Equitable transaction and increased investment income. However, the year-to-date adjusted operating income saw a slight decline, and a substantial loss from the annual assumption review in the EMEA Traditional segment highlights ongoing challenges in certain markets. The company's liquidity and capital position remain robust, indicating a generally positive but mixed performance.

Positives

• Net income available to RGA, Inc. shareholders increased significantly by $97 million in Q3 2025 compared to Q3 2024, reaching $253 million.
• Diluted earnings per share rose substantially to $3.81 in Q3 2025 from $2.33 in Q3 2024.
• Pre-tax income increased by $106 million for Q3 2025 and $275 million for the nine months ended September 30, 2025.
• The reinsurance transaction with Equitable Holdings, Inc. contributed positively, adding $37 million to U.S. Financial Solutions adjusted operating income and a $21 million gain to U.S. Traditional segment in Q3 2025.
• Net investment income saw strong growth, increasing by $287 million in Q3 2025 and $884 million year-to-date, driven by an expanded invested asset base and higher new money rates.
• Total cash and invested assets increased substantially to $132.2 billion as of September 30, 2025, from $101.4 billion at December 31, 2024.
• Life reinsurance in force grew to $4,320.8 billion, indicating continued business expansion.
• Gross unrealized gains on fixed maturity securities available-for-sale increased from $1.2 billion at December 31, 2024, to $1.8 billion at September 30, 2025.
• The company maintains a strong liquidity position with $5.0 billion in cash and short-term investments as of September 30, 2025.
• Management believes the current capital base is adequate and does not anticipate needing to augment capital even if interest rates remain at current levels for the next five years.
• No material defaults have been experienced in retrocession arrangements, and no difficulties in collecting claims recoverable from retrocessionaires have been reported.

Negatives

• The annual assumption review in Q3 2025 resulted in a $149 million loss, primarily due to updated mortality assumptions in the U.K. (EMEA Traditional segment).
• Net premiums decreased by $111 million in Q3 2025 and $1,237 million year-to-date, mainly due to single premium pension risk transfer transactions executed in the prior year.
• Adjusted operating income before income taxes for the nine months ended September 30, 2025, decreased by $30 million, primarily due to unfavorable claims experience in the U.S. Traditional segment and increased operating/financing costs.
• Variable investment income from limited partnerships and real estate joint ventures decreased, impacting overall investment yield for Q3 2025.
• Operating and financing costs increased to support new business growth, compliance requirements, and information technology security.
• Gross unrealized losses on fixed maturity securities available-for-sale remained high at $6.5 billion as of September 30, 2025.
• The EMEA Traditional segment experienced significant decreases in adjusted operating income due to a $222 million net unfavorable assumption update in Q3 2025.

Risks

• Changes in mortality, morbidity, policyholder behavior, claims experience, investment returns, interest rates, and expenses compared to pricing assumptions.
• Investment results, whether from changes in economic, capitaland credit-market conditions, asset selection, or otherwise, and their impact on investment securities, liquidity, portfolio yields, credit quality, access to capital, and capital required for regulatory and contractual purposes.
• Changes in financial strength and credit ratings and the effect of such changes on the company, including triggering terms in derivative agreements.
• The availability, amount, cost, and market value of collateral necessary for regulatory reserves, capital, and client obligations.
• Changes in laws and regulations, tax policy and rates, accounting standards, and privacy and cybersecurity regulations applicable to the company and actions by regulators.
• Regulatory restrictions on the ability of company subsidiaries to pay dividends to the company.
• The stability of and actions by governments, central banks, and economies in jurisdictions where the company operates, affecting interest rates, markets generally, or the demand for insurance and reinsurance.
• The stability and financial performance of clients, reinsurers, third-party investment managers, and other institutions, and the effects of the company's dependence on such third parties.
• The effectiveness of the company's risk management strategy, policy, and procedures, whether relating to reinsurance, investment strategy, operations, or otherwise.
• The impact of impairments of the value of investment securities on capital requirements, and the highly subjective nature of determining allowances and impairments.
• The threat of pandemics, epidemics, other major health issues, natural disasters, catastrophes, and terrorist attacks.
• Competitive factors and competitors' responses to the company's initiatives.
• Difficulties in integrating acquired blocks of business and entities, including the transaction entered into with subsidiaries of Equitable Holdings, Inc. on July 31, 2025.
• Interruption or failure of telecommunication, information technology, or other operational systems, or failure to maintain adequate security to protect data.
• Adverse developments with respect to litigation, arbitration, or regulatory investigations or actions.
• Fluctuation in foreign currency exchange rates.
• The due diligence process undertaken for the Equitable transaction may not have revealed all relevant facts, potentially leading to undiscovered obligations and liabilities.
• Assumptions made relating to the Equitable transaction (e.g., pricing, investment repositioning, future revenue, expenses, unknown liabilities) may prove to be materially inaccurate.
• Reliance on Equitable for various services (timely/accurate information, underwriting decisions, policy administration, investment advice) exposes the company to Equitable's acts or omissions, including cybersecurity risks.
• Assets backing modified coinsurance reserves retained by Equitable are not expected to be available to the company to satisfy amounts Equitable owes in the event of counterparty insolvency.
• Risk of loss if modified coinsurance assets are not managed in accordance with applicable policy terms or related regulatory requirements.

Future Outlook

Management believes that cash flows from available sources will provide sufficient liquidity for the next twelve months, even under stress scenarios. The company performs periodic liquidity stress testing and does not expect to be required to augment capital, even if interest rates remain at current levels for the next five years, assuming all other factors remain constant. The tax impact of the Global Minimum Tax rules and Bermuda's corporate income tax regime is expected to be immaterial, as is the impact of the Inflation Reduction Act of 2022.

Management Comments

• Management does not believe that loss contingencies arising from pending legal, regulatory and governmental matters will have a material adverse effect on the financial condition, results of operations or cash flows of the Company.
• Management believes that RGA's cash flows will be sufficient to enable RGA to meet its obligations for at least the next 12 months.
• Management believes that the Company's current capital base is adequate to support its business at current operating levels.
• The Company does not undertake any obligation to update these forward-looking statements, even though the Company's situation may change in the future, except as required under applicable securities law.

Industry Context

The reinsurance industry continues to navigate a complex environment characterized by sustained low interest rates followed by significant increases in risk-free rates and volatile equity markets. The Equitable transaction reflects an ongoing trend of large block transfers and consolidation within the life insurance and reinsurance sector, as companies seek to optimize capital and risk profiles. Furthermore, global tax reforms, such as the OECD's Global Minimum Tax and Bermuda's new corporate income tax regime, are prompting multinational enterprises, including reinsurers, to adapt to evolving tax landscapes. Mortality and morbidity risks remain the most significant for the company, aligning with broader life reinsurance industry concerns.

Legal Proceedings

• The company is subject to litigation and regulatory investigations or actions from time to time.
• Management does not believe that loss contingencies arising from pending legal, regulatory, and governmental matters will have a material adverse effect on the financial condition, results of operations, or cash flows.
• A legal reserve is established when an arbitration demand, litigation, or regulatory action is probable to result in a loss and the amount can be reasonably estimated.

Related Party Transactions

• Papara Financing LLC, a subsidiary of RGA Reinsurance Company, issued nonconvertible preferred interests totaling $90 million to an unaffiliated third party, included in noncontrolling interest.
• Ruby Reinsurance Company (Ruby Re), a Missouri-domiciled life reinsurance company, was launched with the company as a sponsor. The company is not an investor in Ruby Re and does not consolidate it. Ceded reinsurance recoverable from Ruby Re was approximately $3.0 billion as of September 30, 2025.
• Certain RGA subsidiaries have entered into intercompany securities lending agreements to efficiently source securities for lending to third parties and for regulatory capital management.

Stakeholder Impact

• Shareholders are positively impacted by increased net income and diluted EPS, continued share repurchase program, and declared quarterly dividend, indicating strong returns and capital management.
• Ceding companies and clients benefit from RGA's capacity for large-scale reinsurance partnerships, as demonstrated by the Equitable transaction, potentially attracting more business seeking capital and risk solutions.
• Employees may see stable or growing opportunities due to the company's focus on new business growth and compliance requirements, though increased operating costs could lead to efficiency initiatives.
• Creditors are assured by the company's active capital management, including new debt issuances and facility agreements, and its compliance with all debt covenants.
• Regulatory bodies are impacted by the company's ongoing compliance with new accounting standards (LDTI, income tax disclosure, expense disaggregation) and global tax rules (Global Minimum Tax, Bermuda CIT).

Next Steps

• Continue to monitor new business opportunities and any associated new capital needs that could arise from the changing financial landscape.
• Manage the integration of the acquired liabilities and assets from the Equitable transaction into the business efficiently and effectively.
• Address the impact of updated mortality assumptions in the U.K. (EMEA Traditional segment) to mitigate future losses.
• Monitor the pace of share repurchase activity based on available cash, alternative uses of excess capital, and stock price.
• Actively manage cash and invested assets to balance quality, diversification, asset/liability matching, liquidity, and investment return.

Key Dates

Recommendation

The company demonstrated strong Q3 2025 financial performance with significant increases in net income and diluted EPS, largely driven by the strategic Equitable transaction and robust net investment income growth. While year-to-date adjusted operating income saw a slight dip and the annual assumption review resulted in a notable loss in one segment, the overall financial health, liquidity position, and capital management strategies (including share repurchases and new debt facilities) are solid. The company's ability to execute large, complex reinsurance deals like Equitable suggests strong market positioning and future growth potential, making it an attractive investment.

Keywords

Reinsurance, Life Reinsurance, Financial Solutions, SEC Filing, 10-Q, RGA, Equitable Holdings, Mortality Risk, Longevity Risk, Asset-Intensive, Pension Risk Transfer, Investment Portfolio, Financial Results, Earnings, Share Repurchase, Subordinated Debentures, Capital Management, Risk Management, Insurance, Q3 2025